Better targeting of preventive services using epidemiological modelling
使用流行病学模型更好地确定预防服务的针对性
基本信息
- 批准号:nhmrc : 465130
- 负责人:
- 金额:$ 130.12万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Strategic Awards
- 财政年份:2007
- 资助国家:澳大利亚
- 起止时间:2007-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this program of research is to improve the effectiveness of chronic disease prevention in Australia. The focus is to develop epidemiological models that can assist policy-makers to make more informed choices of which preventive programs to fund, improve the ability of clinicians to provide accurate preventive advice and to increase the ability of consumers to make decisions about preventive activities (that may relate to themselves or their communities). Australian population trends over coming years will be dominated by increasing numbers of elderly and a continuing increase in average lifespan. A priority for preventive healthcare is to maintain the elderly in a healthy active state, free of chronic disease, for as long as possible. Options to achieve this are increasing but vary in terms of likely effectiveness and cost-effectiveness. Since many of the costs and benefits of preventive programs occur beyond the time-scale of major intervention trials, the prediction of long-term benefits requires the integration of information from multiple sources including trials, epidemiological studies, risk-factor surveys and demography through a process referred to as epidemiological modelling. This project has major relevance to consumers, allied health professionals and Aboriginal and Torres Strait Islander people. One outcome of the project will be to allow consumers to make informed decisions about their preventive health care and will assist allied health professionals providing preventive advice to patients. These include occupational health nurses, health promotion officers, Aboriginal health workers and nurse practitioners.
这项研究计划的目的是提高澳大利亚慢性病预防的有效性。重点是开发流行病学模型,帮助决策者更明智地选择资助哪些预防方案,提高临床医生提供准确预防建议的能力,并提高消费者对预防活动(可能与他们自己或他们的社区有关)做出决定的能力。未来几年,澳大利亚人口趋势将主要是老年人数量的增加和平均寿命的持续延长。预防性保健的一个优先事项是尽可能长时间地使老年人保持健康活跃的状态,不患慢性病。实现这一目标的备选方案正在增加,但在可能的有效性和成本效益方面各不相同。由于预防方案的许多成本和效益发生在重大干预试验的时间范围之外,因此预测长期效益需要通过称为流行病学建模的过程整合来自多个来源的信息,包括试验、流行病学研究、风险因素调查和人口统计学。该项目对消费者、专职保健人员以及土著居民和托雷斯海峡岛民具有重大意义。该项目的成果之一将是使消费者能够就其预防保健作出知情决定,并将协助专职保健人员向患者提供预防咨询。这些人员包括职业保健护士、健康促进官员、土著保健工作者和执业护士。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Anna Peeters其他文献
Prof Anna Peeters的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Anna Peeters', 18)}}的其他基金
Decreasing social inequalities in obesity
减少肥胖引起的社会不平等
- 批准号:
nhmrc : GNT1045456 - 财政年份:2013
- 资助金额:
$ 130.12万 - 项目类别:
Career Development Fellowships
Identifying policies to improve social inequalities in obesity, diabetes and cardiovascular disease- understanding the pathways and modelling the outcomes
确定改善肥胖、糖尿病和心血管疾病方面的社会不平等的政策——了解途径并对结果进行建模
- 批准号:
nhmrc : 1045456 - 财政年份:2013
- 资助金额:
$ 130.12万 - 项目类别:
Career Development Fellowships
What will it take to decrease socio-economic inequalities in obesity?
如何减少肥胖带来的社会经济不平等?
- 批准号:
LP120100418 - 财政年份:2012
- 资助金额:
$ 130.12万 - 项目类别:
Linkage Projects
Global Corporate Challenge Evaluation: The evaluation of a low-cost, low-impact physical-activity workplace intervention
全球企业挑战评估:低成本、低影响的体力活动工作场所干预措施的评估
- 批准号:
LP0989603 - 财政年份:2009
- 资助金额:
$ 130.12万 - 项目类别:
Linkage Projects
相似国自然基金
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
- 批准号:81970829
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
- 批准号:81873493
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
- 批准号:81102033
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
- 批准号:31171278
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault.
开发一种针对焦虑敏感性的数字疗法,以减少性侵犯后寻求紧急护理的女性的 PTSD-SUD。
- 批准号:
10449766 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis
结直肠癌的饮食预防:针对胆汁酸/肠道微生物组轴
- 批准号:
10723195 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Targeting neuronal transport to ameliorate vincristine neurotoxicity
靶向神经元运输以改善长春新碱神经毒性
- 批准号:
10736789 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
肝脏靶向二氢喹嗪酮 (DHQ) 分子作为乙型肝炎病毒抗病毒药物,毒性降低
- 批准号:
10593566 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Targeting DKK1 with a DNA Vaccine to Prevent Development of Multiple Myeloma
用 DNA 疫苗靶向 DKK1 预防多发性骨髓瘤的发展
- 批准号:
10874135 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk.
COVID-19 时代艾滋病毒的面貌不断变化:通过动态定位当前和未来的感染风险分布,最大限度地降低艾滋病毒发病率。
- 批准号:
10548290 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Mucosal immune biomarkers to detect neonatal leaky gut
用于检测新生儿肠漏的粘膜免疫生物标志物
- 批准号:
10646527 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别:
Synthesizing immunoinformatics and genetic epidemiology to identify signatures of natural functional immunity to malaria parasites
综合免疫信息学和遗传流行病学,以确定对疟疾寄生虫的天然功能免疫特征
- 批准号:
10642330 - 财政年份:2023
- 资助金额:
$ 130.12万 - 项目类别: